Home / Resources / Quick Listen: Scrip's Five Must-know Things

Quick Listen: Scrip's Five Must-know Things

Podcast Commercial

In this week's podcast edition of Five Must-know Things: Lilly wows ADA with obesity results; Novo’s oral semaglutide data; first DMD gene therapy approved; the outlook for biopharma fundraising; and Korean pharma considers strategy in a changing world.

Related products
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
The go-to resource for informing clinical trial strategy, design and execution
Analyst using Datamonitor Healthcare for a market assesment.
Datamonitor Healthcare
Analysis and data tools for pharma market assessments without the guesswork
Professionals accessing Scrip for the latest industry news and developments to gain advantage on competition.
Scrip
Global pharmaceutical industry news that goes beyond the headlines

Related resources

a woman sitting at a table talking to a doctor
JUN 14, 2023
Article
Commercial

Patient Voice to Data: How Novartis Is Listening Up, Harnessing RWE in APMA

Novartis APAC President Iris Zemzoum says Novartis is empowering patients and also partnering across the diverse region to leverage real-world evidence.

Biopharma Deal-Making Roundup
APR 01, 2023
White paper
Commercial

2022 Deal-Making Roundup

An overview of alliance, M&A, and financing deal activity across the worldwide biopharma, medical device, and in vitro diagnostics industries during 2022

Globe focusing on the Asia Pacific region.
JUL 13, 2023
Press Release
Clinical

Citeline Appoints Clinrol as Strategic Clinical Trial Partner Across APAC Region

Citeline announces a strategic partnership with Clinrol, a clinical trial recruitment company, to expand and enhance patient recruitment for upcoming clinical trials across the Asia-Pacific (APAC) region.

View All Resources